Page 3 - Last Accessed News Today

Galapagos Biotech LTD announces that the National Institute of Health and Clinical Excellence (NICE) has recommended the use of JYSELECA® (filgotinib) for the treatment of adults with moderately to severely active Ulcerative Colitis (UC) when other treatments have not been successful....

If you are a fan of starting the new year with a clean slate, then perhaps now, at the beginning of the year, it is worth doing a digital cleaning and putting your Internet life in order. In this article, we gathered some important digital cleaning methods and tips that will do the job.

Targeted Axillary Dissection (TAD) is a new surgical technique that allows surgeons to assess cancer in specific lymph nodes while minimizing the patient's risk of developing lymphedema linked to their

/CNW/ - Novo Nordisk announced today that Health Canada has approved Wegovy™ (semaglutide injection), the first-and-only prescription weight-loss medication...

Press release content from Business Wire. The AP news staff was not involved in its creation.

NICE uphold appeal by Kyowa Kirin, for POTELIGEO in the treatment of those living with certain ultra-rare blood cancers The National Institute for Health and Care Excellence (NICE) has upheld an appeal

/PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the new drug application (NDA) for Wegovy™...

Kyowa Kirin Responds to the National Institute for Health and Care Excellence (NICE) Decision to Not Provide People Living With Certain Rare Blood Cancers Access to POTELIGEO (mogamulizumab) two very rare forms of non-Hodgkin lymphoma will not have access to an innovative systemic treatment following NICEs decision to not recommend mogamulizumab for routine use in the NHS . Kyowa Kirin is disappointed by this decision but remains committed to finding a resolution with NICE. The National Instit...